Latest news
Loading news…
Hubble Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Hanover, New Hampshire, United States Founded 2000 1-10 employees For Profit
Hubble Therapeutics is a biotechnology research company that offers gene therapy for leber congenital amaurosis type 16.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- IT spend
- $63K
Company Info
- Founded
- 2000
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 7
- HQ
- Hanover, New Hampshire, United States
- Region
- East Coast, New England, Northeastern US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 1.9
- Trend (90d)
- 0.2
Key People at Hubble Therapeutics
Founder & President
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Hubble Therapeutics
Loading news…
FAQs about Hubble Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.